The UK drugmaker AstraZeneca has agreed to acquire Belgian cell therapy developer EsoBiotec for up to $1bn to enhance its cancer treatment capabilities. Read more.
A supply chain attack on a GitHub Actions tool has put up to 23,000 organisations at risk of having credentials stolen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback